In our study, we confirmed that miR-1275 upregulated by genistein can attenuate HCC progression and metastasis by suppressing the EIF5A2/PI3K/Akt signaling pathway to inhibit the EMT and stemness of HCC cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.